APhA WOULD PULL ENDORSEMENT OF PAID NETWORK IF PHARMACISTS ARE NOT "ADEQUATELY COMPENSATED"; NEXT LEVEL OF INCENTIVES TO BE UNVEILED AT APhA ANNUAL MEETING
The American Pharmaceutical Association is prepared to retract its endorsement of Medco/PAID's "Coordinated Care Network" if pharmacists are not compensated adequately in the second phase of the program, APhA trustee elect Ronald Jordan told the Northeast Pharmaceutical Conference March 3.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth